HERV-K

SILVER SPRING, Md., July 15, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...

COPENHAGEN, Denmark & NEW YORK, USA, July 15, 2026 HERVolution Therapeutics ApS, a biotechnology company developing human endogenous retrovirus...